You are here:
Publication details
Farmakoekonomické hodnocení cetuximabu a panitumumabu v 1. linii léčby mCRC v reálné klinické praxi ČR
Title in English | The Pharmacoeconomic Analysis of Cetuximab and Panitumumab in the 1st Line Treatment of mCRC in Real Clinical Practice in the Czech Republic. |
---|---|
Authors | |
Year of publication | 2019 |
Type | Article in Periodical |
Magazine / Source | Klinická onkologie |
MU Faculty or unit | |
Citation | |
Web | https://www.linkos.cz/english-summary/klinicka-onkologie-journal/2019-08-15-4-en/farmakoekonomicke-hodnoceni-cetuximabu-a-panitumumabu-v-1-linii-lecby-mcrc-v-rea-1/ |
Doi | http://dx.doi.org/10.14735/amko2019288 |
Keywords | cetuximab; panitumumab; colorectal carcinoma; cost analysis |
Description | Cost and effectiveness analysis of EGFR inhibitors cetuximab or panitumumab in the first line treatment of metastatic colorectal cancer in the Czech Republic |
Related projects: |